Valuation : Medpace Holdings, Inc.

Market Cap 16.55B 14.24B 13.36B 12.23B 22.82B 1,565B 23B 158B 61.57B 800B 62.16B 60.8B 2,575B P/E 2026 *
33.7x
P/E 2027 * 30.9x
Enterprise Value 15.75B 13.55B 12.72B 11.63B 21.72B 1,489B 21.89B 150B 58.58B 761B 59.14B 57.85B 2,450B EV / Sales 2026 *
5.52x
EV / Sales 2027 * 5.05x
Free-Float
80.34%
Yield 2026 *
-
Yield 2027 * -
1 day-0.22%
1 week-3.16%
Current month-0.30%
1 month+3.30%
3 months+31.37%
6 months+27.25%
Current year+5.44%
1 week 581.78
Extreme 581.78
609.22
1 month 563.45
Extreme 563.45
629.69
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
27/08/26 Sell

Chief Executive Officer

-650 0.0023%
26/08/26 Exercice

Director

11,574 0.0415%
26/08/26 Sell

Chief Executive Officer

-4,000 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-0.13%-3.16%+23.06%+123.39% 16.55B
-0.24%-1.09%+2.00%+17.50% 50.14B
+0.71%-4.85%+429.12%+524.61% 44.85B
+2.48%+3.05%+46.46%+22.41% 43.43B
-0.03%-2.83%+7.64%+76.70% 41.14B
+0.43%-3.26%+14.75%+49.08% 32.92B
+1.16%+8.25% - - 17.56B
+0.93%+0.88%+19.64%+29.70% 14.65B
+0.45%-1.16%+80.48%+43.41% 13.93B
+2.35%-3.82%-9.32%-36.89% 12.33B
Average +0.77%-1.23%+68.20%+94.44% 28.75B
Weighted average by Cap. +0.68%-1.31%+88.31%+121.42%

Financials

2026 *2027 *
Net sales 2.85B 2.45B 2.3B 2.11B 3.93B 270B 3.96B 27.24B 10.61B 138B 10.71B 10.48B 444B 3.03B 2.6B 2.44B 2.24B 4.17B 286B 4.21B 28.91B 11.26B 146B 11.37B 11.12B 471B
Net income 503M 432M 406M 371M 693M 47.51B 698M 4.8B 1.87B 24.28B 1.89B 1.85B 78.19B 547M 470M 441M 404M 754M 51.67B 760M 5.22B 2.03B 26.41B 2.05B 2.01B 85.04B
Net Debt -802M -690M -648M -593M -1.11B -75.84B -1.11B -7.66B -2.98B -38.76B -3.01B -2.95B -125B -1.25B -1.08B -1.01B -925M -1.73B -118B -1.74B -11.96B -4.66B -60.49B -4.7B -4.6B -195B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
03/09/26 $592.85 -0.03% 98,018
02/09/26 $593.02 +1.68% 204,197
01/09/26 $583.21 -1.81% 179,867
31/08/26 $593.99 -1.11% 347,286
28/08/26 $600.65 -1.79% 186,917
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
593.02USD
Average target price
581.83USD
Spread / Average Target
-1.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock